Trial intelligence / Profile preview

Antibiotic Elution from Intra-articular Vancomycin and Tobramycin in TKA

NCT04297631Phase 4Completed

Sponsor
Washington University School of Medicine
Start
Feb 2020
Primary completion
Aug 2020
Modality
Cyclic Peptides, Antimicrobial Peptides, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of vancomycin, tobramycin in periprosthetic joint infection (PJI), sponsored by Washington University School of Medicine. Started Feb 2020; status: completed.

02

Drugs

vancomycintobramycin
03

Conditions

periprosthetic joint infection (PJI)

Beyond the preview

Go deeper on NCT04297631.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04297631.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call